Market closedNon-fractional

Ocugen, Inc/OCGN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Ocugen, Inc

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Ticker

OCGN

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Malvern, United States

Employees

65

Ocugen, Inc Metrics

BasicAdvanced
$422M
Market cap
-
P/E ratio
-$0.23
EPS
3.80
Beta
-
Dividend rate
$422M
3.8
1.869
1.643
16.348
22.577
-50.40%
-108.76%
62.617
13.97
13.97
-6.304
125.42%
-41.03%
435.61%
-3.51%

What the Analysts think about Ocugen, Inc

Analyst Ratings

Majority rating from 3 analysts.
Buy

Ocugen, Inc Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-1,190.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1M
-83.33%
Net income
-$12M
26.60%
Profit margin
-1,190.00%
659.61%

Ocugen, Inc Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 21.05%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.10
-$0.06
-$0.03
-$0.05
-
Expected
-$0.07
-$0.07
-$0.07
-$0.06
-$0.05
Surprise
36.36%
-14.29%
-53.85%
-21.05%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Ocugen, Inc stock?

Ocugen, Inc (OCGN) has a market cap of $422M as of July 06, 2024.

What is the P/E ratio for Ocugen, Inc stock?

The price to earnings (P/E) ratio for Ocugen, Inc (OCGN) stock is 0 as of July 06, 2024.

Does Ocugen, Inc stock pay dividends?

No, Ocugen, Inc (OCGN) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Ocugen, Inc dividend payment date?

Ocugen, Inc (OCGN) stock does not pay dividends to its shareholders.

What is the beta indicator for Ocugen, Inc?

Ocugen, Inc (OCGN) has a beta rating of 3.8. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Ocugen, Inc stock

Buy or sell Ocugen, Inc stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing